ArriVent BioPharma, Inc. (AVBP) › Operating IncomeArriVent BioPharma, Inc. (AVBP) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2023: -$74.59M2024: -$94.31M2025: -$177.53M-$177.53M2023Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$177.53M-88.2%2024-$94.31M-26.4%2023-$74.59M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share